Hyperthermic intraperitoneal chemotherapy with oxaliplatin—Still not the standard of care for patients with colorectal peritoneal metastases

Ítems similars

• Reply to ‘Hyperthermic intraperitoneal chemotherapy with oxaliplatin—Still not standard of care for patients with colorectal peritoneal metastases’ by Julianov and Saroglu
  per: de Jong, Loek A.W., et al.
  Publicat: (2019)
• Comparison of hyperthermic intraperitoneal chemotherapy regimens for treatment of peritoneal-metastasized colorectal cancer
  per: Spiegelberg, Julia, et al.
  Publicat: (2020)
• Organoids from colorectal peritoneal metastases as a platform for improving hyperthermic intraperitoneal chemotherapy
  per: Ubink, I., et al.
  Publicat: (2019)
• The importance of synchronicity in the management of colorectal peritoneal metastases with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
  per: Wong, Jolene Si Min, et al.
  Publicat: (2020)
• Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal metastases
  per: Mirnezami, Reza, et al.
  Publicat: (2014)